Raia Drogasil (BSP:RADL3) EV-to-EBIT : 26.93 (As of Apr. 26, 2024)

View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Raia Drogasil's Enterprise Value is R$50,597 Mil. Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was R$1,879 Mil. Therefore, Raia Drogasil's EV-to-EBIT for today is 26.93.

The historical rank and industry rank for Raia Drogasil's EV-to-EBIT or its related term are showing as below:

BSP:RADL3' s EV-to-EBIT Range Over the Past 10 Years
Min: 20.9 Med: 38.21 Max: 649.72
Current: 26.94

During the past 13 years, the highest EV-to-EBIT of Raia Drogasil was 649.72. The lowest was 20.90. And the median was 38.21.

BSP:RADL3's EV-to-EBIT is ranked worse than
67.83% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 18.61 vs BSP:RADL3: 26.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Raia Drogasil's Enterprise Value for the quarter that ended in Dec. 2023 was R$57,130 Mil. Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was R$1,879 Mil. Raia Drogasil's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.29%.

Raia Drogasil EV-to-EBIT Historical Data

The historical data trend for Raia Drogasil's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil EV-to-EBIT Chart

Raia Drogasil Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

38.45

51.83

35.24

26.26

29.94

Raia Drogasil Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															26.26	25.33	31.57	29.38	29.94

Competitive Comparison of Raia Drogasil's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Raia Drogasil's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raia Drogasil's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's EV-to-EBIT falls into.

Raia Drogasil EV-to-EBIT Calculation

Raia Drogasil's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	50596.616	/	1878.66
	=	26.93

Raia Drogasil's current Enterprise Value is R$50,597 Mil.
Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1,879 Mil.

Raia Drogasil (BSP:RADL3) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Raia Drogasil's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	1878.66	/	57130.215
	=	3.29 %

Raia Drogasil's Enterprise Value for the quarter that ended in Dec. 2023 was R$57,130 Mil.
Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1,879 Mil.

Raia Drogasil EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil (BSP:RADL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

RADLY:USA

Address

Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000

Website

https://ri.rd.com.br

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines